行情

CDNA

CDNA

CareDx
NASDAQ

实时行情|Nasdaq Last Sale

67.97
+0.63
+0.94%
盘后: 67.97 0 0.00% 16:19 09/17 EDT
开盘
68.34
昨收
67.34
最高
68.95
最低
67.17
成交量
99.86万
成交额
--
52周最高
99.83
52周最低
30.27
市值
35.77亿
市盈率(TTM)
-379.5087
分时
5日
1月
3月
1年
5年
Miromatrix 欢迎 John Barry 博士担任研发副总裁
EDEN PRAIRIE, Minn., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced t...
GlobeNewswire · 09/09 12:00
内幕交易:Caredx
MT Newswires · 09/08 11:28
华尔街喜爱的 Cathie Wood 的 ARK 基因组革命基金中的 3 只股票
StockNews.com · 09/07 13:05
10 只正在失势的 Reddit YOLO 股票
In this article, we discuss the 10 Reddit YOLO stocks that are losing ground. If you want to skip our detailed analysis of these stocks, go directly to the 5 Reddit YOLO Stocks That Are Losing Ground. Retail investors have become an important market force ...
Insider Monkey · 09/04 13:07
Vera Therapeutics 加速收益达到三个月高点
After a ~9.5% rise on Wednesday, Vera Therapeutics (NASDAQ:VERA) has added more than a tenth to its market cap so far, driving the shares to reach the highest level since
Seekingalpha · 09/02 19:10
CareDx 将参加即将举行的会议
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for...
GlobeNewswire · 09/02 11:00
CareDx (CDNA) 是现在购买的好股票吗?
Baron Discovery Fund recently published its second-quarter commentary – a copy of which can be downloaded here. During the second quarter of 2021, the Baron Discovery Fund returned 6.07% (institutional shares). In comparison, the benchmark S&P 500 Index wa...
Insider Monkey · 09/02 05:04
CNBC PRO Talks:明星小盘股经理张艾米公布她的首选股票
Amy Zhang, portfolio manager of the Alger Small Cap Focus, Small Cap Growth and Mid Cap Focus strategies and Mid Cap 40 ETF, joins CNBC's Brian Sullivan to discuss the state of the small and mid-cap market, and the rationale for some of her top picks.
CNBC.com · 09/01 19:49
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解CDNA最新的财务预测,通过CDNA每股收益,每股净资产,每股现金流等数据分析CareDx近期的经营情况,然后做出明智的投资选择。
分析师评级

7位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测CDNA价格均价为107.33,最高价位118.00,最低价为100.00。
EPS
机构持股
总机构数: 339
机构持股: 6,355.66万
持股比例: 120.77%
总股本: 5,262.72万
类型机构数股数
增持
73
504.86万
建仓
48
159.45万
减持
103
375.58万
平仓
37
29.26万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
+0.49%
制药与医学研究
-0.10%
高管信息
Chairman/Executive Director
Peter Maag
President/Chief Executive Officer/Director
Reginald Seeto
Chief Financial Officer
Ankur Dhingra
Chief Marketing Officer
Sasha King
Vice President/Controller
Marcel Konrad
Other
Alexander Johnson
Lead Director/Independent Director
Michael Goldberg
Director
Arthur Torres
Director
Hannah Valantine
Independent Director
George Bickerstaff
Independent Director
Frederick Cohen
Independent Director
Grace Colon
Independent Director
Christine Cournoyer
Independent Director
William Hagstrom
Independent Director
Ralph Snyderman
暂无数据
CDNA 简况
CareDx, Inc.是一家分子诊断公司。该公司主要从事多种移植临床诊断监测解决方案的发现、开发和商业化业务。该公司的商业化测试解决方案AlloMap心脏移植分子检测(AlloMap)是一项基因表达测试,可帮助临床医师监测与鉴定具有稳定移植物功能以及低概率中度/重度急性细胞排斥性的心脏移植受体。该公司开发的移植监测产品包括处于开发阶段的移植监测解决方案AlloSure,该解决方案应用下一代测序来检测与定量捐赠心脏血液中的供体来源无细胞脱氧核糖核酸(dd-cfDNA)之间的遗传差异。该公司提供AlloMap Score Variability服务,主要提供个性化长期护理心脏移植受体的补充信息。

微牛提供CareDx Inc(NASDAQ-CDNA)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的CDNA股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易CDNA股票基本功能。